Anti-CD28 Antibody (Theralizumab)
Catalog No.
F1386
Anti-CD28 Antibody (Theralizumab)
Featured Products
Theralizumab (TGN1412) is a humanized IgG4 superagonist anti-CD28 monoclonal antibody that can directly stimulate T cells. Theralizumab can cause cytokine storm (CRS). Theralizumab can be used in the study of rheumatoid arthritis.
146.22 kDa
Dry ice
906068-56-2
-80°C
2 years
Liquid
See label
For reconstitution, we recommend adding sterile, distilled water to achieve a final antibody concentration. Gently shake it to solubilize the protein completely. Do not vortex.
CHO
Terelizumab, TAB-08, TABO-8
100 mM Pro 20 mM Arg pH 5.0. No preservative!
P10747
Human
Unconjugated
Monoclonal
IgG4
ELISA, FACS, Kinetics, Functional assay, Animal Model
CD28
Please avoid freeze-thaw cycles.